Cited by 218Fatty Acid Research and HealthAlzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

The DOI matches its Crossref record; 81 of the 83 references it cites were found in a registry or an index.

Omega-3 Fatty Acids and Neurodegenerative Diseases: New Evidence in Clinical Trials

Open access

Avallone, Rossella, Vitale, Giovanni, Bertolotti, Marco·2019·International Journal of Molecular Sciences

DOI 10.3390/ijms20174256PMC PMC6747747

Published version of a preprint

Open this paper in CoChat — free account Open PDF

Abstract

A nutritional approach could be a promising strategy to prevent or slow the progression of neurodegenerative diseases such as Parkinson’s and Alzheimer’s disease, since there is no effective therapy for these diseases so far. The beneficial effects of omega-3 fatty acids are now well established by a plethora of studies through their involvement in multiple biochemical functions, including synthesis of anti-inflammatory mediators, cell membrane fluidity, intracellular signaling, and gene expression. This systematic review will consider epidemiological studies and clinical trials that assessed the impact of supplementation or dietary intake of omega-3 polyunsaturated fatty acids on neurodegenerative diseases such as Parkinson’s and Alzheimer’s diseases. Indeed, treatment with omega-3 fatty acids, being safe and well tolerated, represents a valuable and biologically plausible tool in the management of neurodegenerative diseases in their early stages.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.3390/ijms20174256

Cites

81 of 81 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The Opposing Effects of N-3 and n-6 Fatty Acids
Schmitz, G., & Ecker, J. (2008) · Progress in Lipid Research · doi:10.1016/j.plipres.2007.12.004 · Cited by 1,245
MIND diet associated with reduced incidence of Alzheimer's disease
Morris, M. C., Tangney, C. C., Wang, Y., Sacks, F. M., Bennett, D. A., & Aggarwal, N. T. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2014.11.009 · Cited by 1,162
Consumption of Fish and n-3 Fatty Acids and Risk of Incident Alzheimer Disease
Morris, M. C., Evans, D. A., Bienias, J. L., Tangney, C. C., Bennett, D. A., Wilson, R. S., Aggarwal, N., & Schneider, J. (2003) · Archives of Neurology · doi:10.1001/archneur.60.7.940 · Cited by 1,135
Omega-6 fatty acids and inflammation
Innes, J. K., & Calder, P. C. (2018) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2018.03.004 · Cited by 935
Dietary fat intake and the risk of incident dementia in the Rotterdam study
Kalmijn, S., Launer, L. J., Ott, A., Witteman, J. C. M., Hofman, A., & Breteler, M. M. B. (1997) · Annals of Neurology · doi:10.1002/ana.410420514 · Cited by 895
Conversion of α-linolenic acid to eicosapentaenoic, docosapentaenoic and docosahexaenoic acids in young women
Burdge, G. C., & Wootton, S. A. (2002) · British Journal Of Nutrition · doi:10.1079/bjn2002689 · Cited by 812
Docosahexaenoic Acid Supplementation and Cognitive Decline in Alzheimer Disease: A Randomized Trial
Quinn, J. F., Raman, R., Thomas, R. G., Yurko-Mauro, K., Nelson, E. B., Van Dyck, C., Galvin, J. E., Emond, J., Jack, C. R., Weiner, M., et al. (2010) · JAMA · doi:10.1001/jama.2010.1510 · Cited by 764
ω-3 Fatty Acid Treatment in 174 Patients With Mild to Moderate Alzheimer Disease: OmegAD Study: A Randomized Double-blind Trial
Freund-Levi, Y., Eriksdotter-Jönhagen, M., Cederholm, T., Basun, H., Faxén-Irving, G., Garlind, A., Vedin, I., Vessby, B., Wahlund, L.-O., & Palmblad, J. (2006) · Archives of Neurology · doi:10.1001/archneur.63.10.1402 · Cited by 751
Dietary patterns and risk of dementia: The Three-City cohort study
Barberger-Gateau, P., Raffaitin, C., Letenneur, L., Berr, C., Tzourio, C., Dartigues, J. F., & Alpérovitch, A. (2007) · Neurology · doi:10.1212/01.wnl.0000278116.37320.52 · Cited by 700
Plasma Phosphatidylcholine Docosahexaenoic Acid Content and Risk of Dementia and Alzheimer Disease: The Framingham Heart Study
Schaefer, E. J., Bongard, V., Beiser, A. S., Lamon-Fava, S., Robins, S. J., Au, R., Tucker, K. L., Kyle, D. J., Wilson, P. W. F., & Wolf, P. A. (2006) · Archives of Neurology · doi:10.1001/archneur.63.11.1545 · Cited by 686
Polyunsaturated fatty acids (PUFA) and eicosanoids in human health and pathologies
Tapiero, H., Ba, G. N., Couvreur, P., & Tew, K. D. (2002) · Biomedicine & Pharmacotherapy · doi:10.1016/s0753-3322(02)00193-2 · Cited by 642
Physiological compartmental analysis of α-linolenic acid metabolism in adult humans
Pawlosky, R. J., Hibbeln, J. R., Novotny, J. A., & Salem, N. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31576-5 · Cited by 593
Significance of long chain polyunsaturated fatty acids in human health
Zárate, R., el Jaber-Vazdekis, N., Tejera, N., Pérez, J. A., & Rodríguez, C. (2017) · Clinical and Translational Medicine · doi:10.1186/s40169-017-0153-6 · Cited by 573
Efficiency of conversion of α-linolenic acid to long chain n-3 fatty acids in man
Brenna, J. T. (2002) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/00075197-200203000-00002 · Cited by 530
Long-chain polyunsaturated fatty acids (LCPUFA) from genesis to senescence: The influence of LCPUFA on neural development, aging, and neurodegeneration
Janssen, C. I. F., & Kiliaan, A. J. (2013) · Progress in Lipid Research · doi:10.1016/j.plipres.2013.10.002 · Cited by 528
Nutrition in Brain Development and Aging: Role of Essential Fatty Acids
Uauy, R. D., & Dangour, A. D. (2006) · Nutrition Reviews · doi:10.1301/nr.2006.may.s24-s33 · Cited by 426
The effects of omega-3 fatty acids monotherapy in Alzheimer's disease and mild cognitive impairment: A preliminary randomized double-blind placebo-controlled study
Chiu, C.-C., Su, K., Cheng, T., Liu, H., Chang, C.-J., Dewey, M. E., Stewart, R. J., & Huang, S. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.05.015 · Cited by 423
Docosahexaenoic acid promotes neurogenesis in vitro and in vivo
Kawakita, E., Hashimoto, M., & Shido, O. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.01.021 · Cited by 410
Metabolism of α-linolenic acid in humans
Burdge, G. C. (2006) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2006.05.013 · Cited by 400
Docosahexaenoic Acid and Cognition throughout the Lifespan
Weiser, M., Butt, C., & Mohajeri, M. (2016) · Nutrients · doi:10.3390/nu8020099 · Cited by 400
Benefits of fatty fish on dementia risk are stronger for those without APOE ε4
Huang, T. L., Zandi, P. P., Tucker, K. L., Fitzpatrick, A. L., Kuller, L. H., Fried, L. P., Burke, G. L., & Carlson, M. C. (2005) · Neurology · doi:10.1212/01.wnl.0000183148.34197.2e · Cited by 384
Scientific Opinion on the Tolerable Upper Intake Level of eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA) and docosapentaenoic acid (DPA)
EFSA Panel on Dietetic Products, N. A. A. (. (2012) · EFSA Journal · doi:10.2903/j.efsa.2012.2815 · Cited by 372
Crosstalk between mitochondrial dysfunction, oxidative stress, and age related neurodegenerative disease: Etiologies and therapeutic strategies
Elfawy, H. A., & Das, B. B. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.12.029 · Cited by 348
Prospective study of dietary pattern and risk of Parkinson disease
Gao, X., Chen, H., Fung, T. T., Logroscino, G., Schwarzschild, M. A., Hu, F. B., & Ascherio, A. (2007) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/86.5.1486 · Cited by 340
Fish, docosahexaenoic acid and Alzheimer’s disease
Cunnane, S. C., Plourde, M., Pifferi, F., Bégin, M. E., Féart, C., & Barberger‐Gateau, P. (2009) · Progress in Lipid Research · doi:10.1016/j.plipres.2009.04.001 · Cited by 336
Neurological Benefits of Omega-3 Fatty Acids
Dyall, S. C., & Michael-Titus, A. T. (2008) · NeuroMolecular Medicine · doi:10.1007/s12017-008-8036-z · Cited by 323
Efficacy of Souvenaid in Mild Alzheimer's Disease: Results from a Randomized, Controlled Trial
Scheltens, P., Twisk, J. W. R., Blesa, R., Scarpini, E. A., Arnim, C. A. F. V., Bongers, A., Harrison, J., Willemsen‐Swinkels, S. H. N., Stam, C. J., de Waal, H., et al. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-121189 · Cited by 314
Efficacy of a medical food in mild Alzheimer's disease: A randomized, controlled trial
Scheltens, P., Kamphuis, P. J. G. H., Verhey, F. R. J., Rikkert, M. G. M. O., Wurtman, R. J., Wilkinson, D. G., Twisk, J. W. R., & Kurz, A. (2010) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2009.10.003 · Cited by 303
A Randomized Placebo-Controlled Pilot Trial of Omega-3 Fatty Acids and Alpha Lipoic Acid in Alzheimer's Disease
Shinto, L., Quinn, J., Montine, T., Dodge, H. H., Woodward, W., Baldauf-Wagner, S., Waichunas, D., Bumgarner, L., Bourdette, D., Silbert, L., et al. (2013) · Journal of Alzheimer's Disease · doi:10.3233/jad-130722 · Cited by 288
How does high DHA fish oil affect health? A systematic review of evidence
Fard, S. G., Wang, F., Sinclair, A. J., Elliott, G., & Turchini, G. M. (2018) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2018.1425978 · Cited by 273
Dietary fatty acids and the risk of Parkinson disease
de Lau, L. M. L., Bornebroek, M., Witteman, J. C. M., Albert Hofman, D., Koudstaal, P. J., & Breteler, M. M. B. (2005) · Neurology · doi:10.1212/01.wnl.0000166038.67153.9f · Cited by 260
Diffusion of docosahexaenoic and eicosapentaenoic acids through the blood–brain barrier: An in situ cerebral perfusion study
Ouellet, M., Émond, V., Chen, C. T., Julien, C., Bourasset, F., Oddo, S., LaFerla, F. M., Bazinet, R. P., & Calon, F. (2009) · Neurochemistry International · doi:10.1016/j.neuint.2009.04.018 · Cited by 227
Diet, nutrition and the ageing brain: current evidence and new directions
Moore, K., Hughes, C., Ward, M., Hoey, L., & McNulty, H. (2018) · Proceedings of The Nutrition Society · doi:10.1017/s0029665117004177 · Cited by 227
The omega-6/omega-3 fatty acid ratio, genetic variation, and cardiovascular disease.
Simopoulos, A. P. (2008) · PubMed · Cited by 224
Omega-3 fatty acids upregulate adult neurogenesis
Beltz, B. S., Tlusty, M. F., Benton, J. L., & Sandeman, D. C. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.01.010 · Cited by 211
Depression in Parkinson’s Disease: A Double-Blind, Randomized, Placebo-Controlled Pilot Study of Omega-3 Fatty-Acid Supplementation
da Silva, T. M., Munhoz, R. P., Alvarez, C., Naliwaiko, K., Kiss, Á., Andreatini, R., & Ferraz, A. C. (2008) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.03.008 · Cited by 205 · cited 8×
“Another double-blind, placebo-controlled study analyzed the effect of fish oil supplementation in parkinsonian patients with depression measured using Montgomery–Asberg rating scale (MADRS), the clinical global impressions scale (CGI) and Beck depression inventory (BDI) [44].”
BackgroundMethodInfluential
Dietary intake of fish and omega-3 fatty acids in relation to long-term dementia risk
Devore, E. E., Grodstein, F., van Rooij, F. J., Hofman, A., Rosner, B., Stampfer, M. J., Witteman, J. C., & Breteler, M. M. (2009) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.27037 · Cited by 205
Relevance of dietary glycerophospholipids and sphingolipids to human health
Castro‐Gómez, P., García-Serrano, A. M., Visioli, F., & Fontecha, J. (2015) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2015.07.004 · Cited by 204
Dietary DHA and health: cognitive function ageing
Cardoso, C. L., Afonso, C. M., & Bandarra, N. M. (2016) · Nutrition Research Reviews · doi:10.1017/s0954422416000184 · Cited by 204
The influence of dietary docosahexaenoic acid and arachidonic acid on central nervous system polyunsaturated fatty acid composition
Brenna, J. T., & Diau, G. (2007) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2007.10.016 · Cited by 202
Environmental, life-style, and physical precursors of clinical Parkinson?s disease: recent findings from the Honolulu-Asia Aging Study
Abbott, R. D., Ross, G. W., White, L. R., Sanderson, W. T., Burchfiel, C. M., Kashon, M. L., Sharp, D. S., Masaki, K., Curb, J. D., & Petrovitch, H. (2003) · Journal of Neurology · doi:10.1007/s00415-003-1306-7 · Cited by 200
Regulation of brain polyunsaturated fatty acid uptake and turnover
Chen, C. T., Green, J. T., Orr, S. K., & Bazinet, R. P. (2008) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2008.09.003 · Cited by 184
Omega‐3 supplementation in mild to moderate Alzheimer's disease: effects on neuropsychiatric symptoms
Freund‐Levi, Y., Basun, H., Cederholm, T., Irving, G. F., Garlind, A., Grut, M., Vedin, I., Palmblad, J. E. W., Wahlund, L., & Eriksdotter, M. (2007) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1857 · Cited by 182
The role of eicosanoids in the brain.
Tassoni, D., Kaur, G., Weisinger, R. S., & Sinclair, A. J. (2008) · PubMed · Cited by 182
Omega-3 fatty acids for the treatment of dementia
Burckhardt, M., Herke, M., Wustmann, T., Watzke, S., Langer, G., & Fink, A. M. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009002.pub3 · Cited by 180
Fatty acid binding proteins in brain development and disease
Liu, R., Mita, R., Beaulieu, M., Gao, Z., & Godbout, R. (2010) · The International Journal of Developmental Biology · doi:10.1387/ijdb.092976rl · Cited by 177
Transfer of omega‐3 fatty acids across the blood–brain barrier after dietary supplementation with a docosahexaenoic acid‐rich omega‐3 fatty acid preparation in patients with A lzheimer's disease: the O meg AD study
Freund‐Levi, Y., Vedin, I., Cederholm, T., Basun, H., Irving, G. F., Eriksdotter, M., Hjorth, E., Schultzberg, M., Vessby, B., Wahlund, L., et al. (2013) · Journal of Internal Medicine · doi:10.1111/joim.12166 · Cited by 165
Association of Docosahexaenoic Acid Supplementation With Alzheimer Disease Stage in Apolipoprotein E ε4 Carriers
Yassine, H. N., Braskie, M. N., Mack, W. J., Castor, K., Fonteh, A. N., Schneider, L. S. S., Harrington, M. G., & Chui, H. C. (2017) · JAMA Neurology · doi:10.1001/jamaneurol.2016.4899 · Cited by 165
The Effects of Omega-3 Fatty Acids and Vitamin E Co-Supplementation on Clinical and Metabolic Status in Patients with Parkinson’s Disease: A Randomized, Double-Blind, Placebo-Controlled Trial
Taghizadeh, M., Tamtaji, O. R., Dadgostar, E., Daneshvar Kakhaki, R., Bahmani, F., Abolhassani, J., Aarabi, M. H., Kouchaki, E., Memarzadeh, M. R., & Asemi, Z. (2017) · Neurochemistry International · doi:10.1016/j.neuint.2017.03.014 · Cited by 162
Omega-3 fatty acids' supplementation in Alzheimer's disease: A systematic review
Canhada, S., Castro, K., Perry, I. S., & Luft, V. C. (2018) · Nutritional Neuroscience · doi:10.1080/1028415x.2017.1321813 · Cited by 156
No Effect of Omega-3 Fatty Acid Supplementation on Cognition and Mood in Individuals with Cognitive Impairment and Probable Alzheimer’s Disease: A Randomised Controlled Trial
Phillips, M., Childs, C., Calder, P., & Rogers, P. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161024600 · Cited by 149
Over-the-Counter Supplement Interventions to Prevent Cognitive Decline, Mild Cognitive Impairment, and Clinical Alzheimer-Type Dementia: A Systematic Review
Butler, M., Nelson, V. A., Davila, H., Ratner, E., Fink, H. A., Hemmy, L. S., McCarten, J. R., Barclay, T. R., Brasure, M., & Kane, R. L. (2018) · Annals of Internal Medicine · doi:10.7326/m17-1530 · Cited by 144
Functional and Structural Benefits Induced by Omega-3 Polyunsaturated Fatty Acids During Aging
Cutuli, D. (2017) · Current Neuropharmacology · doi:10.2174/1570159x14666160614091311 · Cited by 139
Fatty Acid-Binding Protein 5 Facilitates the Blood–Brain Barrier Transport of Docosahexaenoic Acid
Pan, Y., Scanlon, M. J., Owada, Y., Yamamoto, Y., Porter, C. J. H., & Nicolazzo, J. A. (2015) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5b00580 · Cited by 136
Enhancing Omega-3 Long-Chain Polyunsaturated Fatty Acid Content of Dairy-Derived Foods for Human Consumption
Nguyen, Q. V., Malau‐Aduli, B. S., Cavalieri, J., Nichols, P. D., & Malau‐Aduli, A. E. O. (2019) · Nutrients · doi:10.3390/nu11040743 · Cited by 129
Dietary fat intake, pesticide use, and Parkinson's disease
Kamel, F., Goldman, S. M., Umbach, D. M., Chen, H., Richardson, G., Barber, M. R., Meng, C., Marras, C., Korell, M., Kasten, M., et al. (2014) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2013.09.023 · Cited by 127
Reduction in DHA transport to the brain of mice expressing human APOE 4 compared to APOE 2
Vandal, M., Alata, W., Tremblay, C., Rioux‐Perreault, C., Salem, N., Calon, F., & Plourde, M. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12640 · Cited by 124
The Effect of Souvenaid on Functional Brain Network Organisation in Patients with Mild Alzheimer’s Disease: A Randomised Controlled Study
de Waal, H., Stam, C. J., Lansbergen, M. M., Wieggers, R. L., Kamphuis, P. J. G. H., Scheltens, P., Maestú, F., & van Straaten, E. C. W. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086558 · Cited by 120
Omega-3 fatty acids, lipids, and apoE lipidation in Alzheimer's disease: a rationale for multi-nutrient dementia prevention
Grimm, M. O. W., Michaelson, D. M., & Hartmann, T. (2017) · Journal of Lipid Research · doi:10.1194/jlr.r076331 · Cited by 114
The S-Connect study: results from a randomized, controlled trial of Souvenaid in mild-to-moderate Alzheimer's disease
Shah, R. C., Kamphuis, P. J., Leurgans, S., Swinkels, S. H., Sadowsky, C. H., Bongers, A., Rappaport, S. A., Quinn, J. F., Wieggers, R. L., Scheltens, P., et al. (2013) · Alzheimer's Research & Therapy · doi:10.1186/alzrt224 · Cited by 112
Plasma Fatty Acid Profiles in Relation to Cognition and Gender in Alzheimer’s Disease Patients During Oral Omega-3 Fatty Acid Supplementation: The OmegAD Study
Eriksdotter, M., Vedin, I., Falahati, F., Freund‐Levi, Y., Hjorth, E., Irving, G. F., Wahlund, L., Schultzberg, M., Basun, H., Cederholm, T., et al. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150102 · Cited by 107
The role of n-3 PUFA-derived fatty acid derivatives and their oxygenated metabolites in the modulation of inflammation
de Bus, I., Witkamp, R. F., Zuilhof, H. T., Albada, B., & Balvers, M. G. J. (2019) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2019.106351 · Cited by 105
Dietary fat intake and risk of Parkinson's disease: A case-control study in Japan
Miyake, Y., Sasaki, S., Tanaka, K., Fukushima, W., Kiyohara, C., Tsuboi, Y., Yamada, T., Oeda, T., Miki, T., Kawamura, N., et al. (2009) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.09.021 · Cited by 100
Omega-3 Fatty Acid Intake by Age, Gender, and Pregnancy Status in the United States: National Health and Nutrition Examination Survey 2003–2014
Thompson, M., Hein, N., Hanson, C., Smith, L. M., Anderson-Berry, A., Richter, C. K., Stessy Bisselou, K., Kusi Appiah, A., Kris-Etherton, P., Skulas-Ray, A. C., et al. (2019) · Nutrients · doi:10.3390/nu11010177 · Cited by 98
Docosahexaenoic acid regulates the formation of lipid rafts: A unified view from experiment and simulation
Wassall, S. R., Leng, X., Canner, S. W., Pennington, E. R., Kinnun, J. J., Cavazos, A. T., Dadoo, S., Johnson, D. J., Heberle, F. A., Katsaras, J., et al. (2018) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2018.04.016 · Cited by 96
Oral administration of circulating precursors for membrane phosphatides can promote the synthesis of new brain synapses
Cansev, M., Wurtman, R. J., Sakamoto, T., & Ulus, İ. H. (2007) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2007.10.005 · Cited by 95
Effects of n-3 FA supplementation on the release of proresolving lipid mediators by blood mononuclear cells: the OmegAD study
Wang, X., Hjorth, E., Vedin, I., Eriksdotter, M., Freund‐Levi, Y., Wahlund, L., Cederholm, T., Palmblad, J. E. W., & Schultzberg, M. (2015) · Journal of Lipid Research · doi:10.1194/jlr.p055418 · Cited by 82
Experimental Evidence of ω -3 Polyunsaturated Fatty Acid Modulation of Inflammatory Cytokines and Bioactive Lipid Mediators: Their Potential Role in Inflammatory, Neurodegenerative, and Neoplastic Diseases
Calviello, G., Su, H., Weylandt, K. H., Fasano, E., Serini, S., & Cittadini, A. R. M. (2013) · BioMed Research International · doi:10.1155/2013/743171 · Cited by 81
Homocysteine Status Modifies the Treatment Effect of Omega-3 Fatty Acids on Cognition in a Randomized Clinical Trial in Mild to Moderate Alzheimer’s Disease: The OmegAD Study
Jernerén, F., Cederholm, T., Refsum, H., Smith, A. D., Turner, C., Palmblad, J. E. W., Eriksdotter, M., Hjorth, E., Irving, G. F., Wahlund, L., et al. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-181148 · Cited by 66
Tolerability and Safety of Souvenaid in Patients with Mild Alzheimer’s Disease: Results of Multi-Center, 24-Week, Open-Label Extension Study
Olde Rikkert, M. G. M., Verhey, F. R., Blesa, R., von Arnim, C. A. F., Bongers, A., Harrison, J., Sijben, J., Scarpini, E., Vandewoude, M. F. J., Vellas, B., et al. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-141305 · Cited by 61
Lipoquality control by phospholipase A2 enzymes
Murakami, M. (2017) · Proceedings of the Japan Academy Series B · doi:10.2183/pjab.93.043 · Cited by 61
Omega-3 PUFA metabolism and brain modifications during aging
Chappus-McCendie, H., Chevalier, L., Roberge, C., & Plourde, M. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.109662 · Cited by 61
Efficacy of a medical food on cognition in Alzheimer's Disease: Results from secondary analyses of a randomized, controlled trial
Kamphuis, P. J. G. H., Verhey, F. R. J., Rikkert, M. G. M. O., Twisk, J. W. R., Willemsen‐Swinkels, S. H. N., & Scheltens, P. (2011) · The journal of nutrition health & aging · doi:10.1007/s12603-011-0105-6 · Cited by 53
Effects on Transthyretin in Plasma and Cerebrospinal Fluid by DHA-Rich n – 3 Fatty Acid Supplementation in Patients with Alzheimer's Disease: The OmegAD Study
Irving, G. F., Freund‐Levi, Y., Eriksdotter, M., Basun, H., Hjorth, E., Palmblad, J. E. W., Vedin, I., Cederholm, T., & Wahlund, L. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-121828 · Cited by 49
Efectividad de la suplementación de ácidos grasos omega-3 en pacientes con enfermedad de Alzheimer: revisión sistemática con metaanálisis
Araya‐Quintanilla, F., Gutiérrez‐Espinoza, H., Sánchez-Montoya, U., Muñoz-Yánez, M. J., Baeza-Vergara, A., Petersen-Yanjarí, M., & Fernández-Lecaros, L. (2017) · Neurología · doi:10.1016/j.nrl.2017.07.009 · Cited by 42
Effect Size Analyses of Souvenaid in Patients with Alzheimer’s Disease
Cummings, J. L., Scheltens, P., McKeith, I. G., Blesa, R., Harrison, J., Bertolucci, P. H. F., Rockwood, K. J., Wilkinson, D. G., Wijker, W., Bennett, D. A., et al. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160745 · Cited by 41
Modulating Effect of Diet on Alzheimer’s Disease
Fernández-Sanz, P., Ruiz-Gabarre, D., & García‐Escudero, V. (2019) · Diseases · doi:10.3390/diseases7010012 · Cited by 41
Effectiveness of omega-3 fatty acid supplementation in patients with Alzheimer disease: A systematic review and meta-analysis
Araya‐Quintanilla, F., Gutiérrez‐Espinoza, H., Sánchez-Montoya, U., Muñoz-Yánez, M. J., Baeza-Vergara, A., Petersen-Yanjarí, M., & Fernández-Lecaros, L. (2020) · Neurología (English Edition) · doi:10.1016/j.nrleng.2017.07.014 · Cited by 41
Omega‐3 fatty acids regulate plasticity in distinct hippocampal glutamatergic synapses
Aryal, S., Hussain, S., Drevon, C. A., Nagelhus, E. A., Hvalby, Ø., Jensen, V., Walaas, S. I., & Davanger, S. (2018) · European Journal of Neuroscience · doi:10.1111/ejn.14224 · Cited by 40
DHA effects in Parkinson disease depression
Pomponi, M., Loria, G., Salvati, S., Biase, A. D., Conte, G. L., Villella, C., Righino, E., Ciciarelli, C., Bria, P., Torre, G. L., et al. (2014) · Basal Ganglia · doi:10.1016/j.baga.2014.03.004 · Cited by 37
Regioisomers of Phosphatidylcholine Containing DHA and Their Potential to Deliver DHA to the Brain: Role of Phospholipase Specificities
Chen, S., & Subbaiah, P. V. (2013) · Lipids · doi:10.1007/s11745-013-3791-5 · Cited by 35

Flagged first, then by citations

2 of the 83 references couldn’t be matched to a known paper.

Sorted by citations

Obesity and aging: Molecular mechanisms and therapeutic approaches
Santos, A. L., & Sinha, S. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101268 · Cited by 249
Futuristic food fortification with a balanced ratio of dietary ω-3/ω-6 omega fatty acids for the prevention of lifestyle diseases
Patel, A., Desai, S. S., Mane, V. K., Enman, J., Rova, U., Christakopoulos, P., & Μάτσακας, Λ. (2022) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2022.01.006 · Cited by 152
Role of n-3 long-chain polyunsaturated fatty acids in human nutrition and health: Review of recent studies and recommendations
Van Dael, P. (2021) · Nutrition Research and Practice · doi:10.4162/nrp.2021.15.2.137 · Cited by 138
DHA/EPA (Omega-3) and LA/GLA (Omega-6) as Bioactive Molecules in Neurodegenerative Diseases
Kousparou, C. A., Fyrilla, M., Stephanou, A., & Patrikios, I. S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241310717 · Cited by 134
Resolvins, Protectins, and Maresins: DHA-Derived Specialized Pro-Resolving Mediators, Biosynthetic Pathways, Synthetic Approaches, and Their Role in Inflammation
Ferreira, I., Falcato, F., Bandarra, N., & Rauter, A. P. (2022) · Molecules · doi:10.3390/molecules27051677 · Cited by 120

See all 218

Authors: Avallone, R., Vitale, G., & Bertolotti, M.
Affiliations: University of Modena and Reggio Emilia (IT)
Corresponding author: Avallone, Rossella
ORCID: Avallone, Rossella
Vitale, Giovanni
Bertolotti, Marco
Venue: International Journal of Molecular Sciences
Publisher: MDPI AG
Published: 2019-08-30
Volume: 20
Issue: 17
Pages: 4256
ISSN: 1422-0067 (ISSN-L)
DOI: 10.3390/ijms20174256
PMC: PMC6747747
OpenAlex: W2963446643
Cited by: 218
References: 83
Citations by year: 2026: 14 · 2025: 43 · 2024: 35 · 2023: 29 · 2022: 37 · 2021: 31 · 2020: 28 · 2019: 1
FWCI: 3.30
Type: journal article
Language: en
Open access: gold
dx.doi.org
Licence: cc-by
creativecommons.org/licenses/by/4.0/ (vor)
Locations: International Journal of Molecular Sciences (publishedVersion, cc-by)
Preprints.org (acceptedVersion, cc-by)
PubMed Central (publishedVersion, cc-by)
PubMed (publishedVersion)
IRIS UNIMORE (University of Modena and Reggio Emilia) (submittedVersion, cc-by)
DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders: Fondazione Cassa di Risparmio di Modena (2018.0334)
Topics: Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords: omega-3 fatty acids, neurodegenerative diseases, Parkinson's disease, Alzheimer's disease, dietary supplementation, polyunsaturated fatty acids, anti-inflammatory mediators, cell membrane fluidity, intracellular signaling, gene expression, disease prevention
MeSH terms: Clinical Trials as Topic, Humans, Fatty Acids, Omega-3, Neurodegenerative Diseases, Observational Studies as Topic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Omega-3 Fatty Acids and Neurodegenerative Diseases: New Evidence in Clinical Trials

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks